(Date:12/2/2009)..., , NEW YORK, Dec. 2 ...arch report is available in its catalogue: ,, ... Global Markets ,, http://www.reportlinker.co...chnologies-Global-Markets.html ,, Provide an i...s resistance and antibiotics technologies ,, Of...
(Date:12/2/2009)..., , WASHINGTON, Dec. 2 /PRNewswire-USNewswi...ector and CEO, Natural Products Association ,,...the U.S. Anti-Doping Agency (USADA) to educate con...s selling steroids as dietary supplements, the Nat...trade association representing retailers and manuf...
(Date:12/2/2009)...Modest improvement seen for advanced cases, study ...ews) -- In the past two decades, survival rates fo...es have improved modestly, a new study has found. ...0 patients diagnosed with stage 4 non-small cell l...ent information was in the U.S. National Cancer In...
(Date:12/2/2009)...Study finds rising incidence of obesity could coun...DNESDAY, Dec. 2 (HealthDay News) -- The overall he...past three decades, largely because people have qu...se gains might soon be wiped out if the rising obe.... , If current trends in both smoking and obesi...
(Date:12/2/2009)...Linemen especially likely to have metabolic syndro...ealthDay News) -- Exercise alone isn,t enough to k... at higher risk for a medical condition that can l...esearchers studied linemen at Division I colleges ... percent had metabolic syndrome, a group of condit...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:Natural Products Association Issues Statement on New Supplement Safety Campaign 2Health News:Gains Made in Lung Cancer Survival 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:Oversized College Football Players May Face Heart Risks 2...& Trust Company (Nasdaq: WAIN ), announced t...ling $10.6 million, including a New Markets Tax Cr...help finance the expansion of Harbor Health Servic...e for the Elderly (PACE) model which is centered a...
... Spine announced today that Lew Bennett has been n...ctors. Mr. Bennett brings with him over 48 years ... retired and re-entered the market six times, Mr. ..."We are really excited to have Lew Bennett taking ...
...livery vectors for ALS , , CAMBRIDGE, Mass. and C... Institute (ALS TDI) and Asklepios BioPharmaceutic... at developing a panel of viral vectors that could...The collaboration between the two research centers...
... Corporation (NYSE:, STE ) today announced that i...ration (FDA) a new liquid chemical sterilization s...llows discussions with the FDA regarding,issues ra...d to the FDA addresses the changes referenced by t...
...es annual revenues, brings on hundreds of new prov... Carefx Corporation today announced 200 percent r...enetration of the hospital, health system, integra...ospitals to its already impressive roster. , , "...
...ientific Corporation (NYSE: BSX ) today announce...tment of Veterans Affairs (VA) for a full line of ...one-year contract took effect last month and has a...pacemakers and the TELIGEN(TM) implantable cardiov...
Other Medicine News:Health News:Wainwright Bank Provides $10.6 Million to Harbor Health Services, Inc. 2Health News:Custom Spine Announces Lew Bennett as President 2Health News:ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrig's Disease 2Health News:ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrig's Disease 3Health News:ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrig's Disease 4Health News:STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter 2Health News:STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter 3Health News:STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter 4Health News:STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter 5Health News:Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making 2Health News:Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making 3Health News:Boston Scientific Awarded CRM Contract by Department of Veterans Affairs 2Health News:Boston Scientific Awarded CRM Contract by Department of Veterans Affairs 3(Date:12/2/2009)..., , LAS ANGELES, December 2 /PRNew...TCBB: FHAI) announced today that it would initiate...eeping them informed of the significant,progress w...usiness plan, as,well as to provide shareholders w... against Dunn Capital Partners and others. , ...
(Date:12/2/2009)..., , CENTENNIAL, Colo., Dec. 2 /PRNewswire...rofit providers of skin, bone and soft tissue allo...d,s largest processor of live cellular bone growth... truly iconic symbol of hope as a float rider aboa...2010 Tournament of Roses Parade®. Manuel Sal...
(Date:12/2/2009)..., , DUBLIN, Ohio, Dec. 2 /PRNewswire-First...ie Cox will serve on the company,s board of direct...cently served as executive vice president and pres... Corp. She completed her tenure with the company a...,, Prior to her term at Schering-Plough, Cox se...
Breaking Medicine Technology:Fountain Healthy Aging Inc Business Update For Shareholders 2Fountain Healthy Aging Inc Business Update For Shareholders 3AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3Cardinal Health Names Carrie Cox to Board of Directors 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 1Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 3H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 1H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 1Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 3...s Driving Nosocomial Pneumonia Prescribing in Ho...SA Guidelines Arlington Medical Resources and Dec...ospital Anti-Infectives Insight Series, MALVERN, ...cal Resources (AMR) and Decision Resources find th... estimate that if approved, Basilea/Johnson &,John...
...t. 22 AstraZeneca today,announced that the United...nted an additional six-month period of exclusivity...sed advanced prostate cancer indication until,Apri...DA in the,investigation of the safety and effectiv...ot be seeking an indication in this population., ...
Other Medicine Technology:Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia 2Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia 3AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 2AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 3AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 4Syringe Avitene
... based upon the physiological form and function of...s and morphology of the implant design integrates ...ysiological spine. Modular design concept: Three i...ls: Forged cobalt-chrome alloy endplate elements, ...
Mach4 Surgical Navigation Software
Kambin Radiolucent Spinal Frame
Medicine Products: